Leenhapong Navaravong

Leenhapong Navaravong, MD

Languages spoken: Thai, English

Academic Information

Departments Adjunct - Internal Medicine

Divisions: Cardiovascular Medicine

Academic Office Information

Board Certification

  • American Board of Internal Medicine (Internal Medicine)
  • American Board of Internal Medicine (Sub: Cardiovascular Disease)
  • American Board of Internal Medicine (Sub: Clinical Cardiac Electrophysiology)

Dr. Navaravong is an Assistant Professor of Medicine in the Division of Cardiovascular Medicine, Section of Clinical Cardiac Electrophysiology.

He received his medical degree from Faculty of Medicine, Siriraj Hospital, Mahidol University in Bangkok, Thailand. He finished his internship at State University of New York-Downstate Medical Center and internal medicine residency at the University of Minnesota. He completed his Cardiovascular Disease Fellowship at Baystate Medical Center in Massachusetts and his Cardiac Electrophysiology Fellowship at the University of Utah.

After graduating from the University of Utah fellowship program, Dr. Navaravong served as a cardiac electrophysiologist in Iowa before returning to the University of Utah as Clinical Faculty.

His primary focus is caring for patients with heart rhythm disorders (irregular, slow or fast heartbeats and arrhythmia related to heart attack and heart dysfunction). He performs many cardiac procedures to help patients with heart rhythm disorders including: loop recorder implantation, pacemaker, cardiac defibrillator, left atrial appendage occlude, and also lead extraction. In addition, Dr. Navaravong also performs catheter-based treatment for heart rhythm disorders, such as: catheter ablation of atrial arrhythmia (atrial fibrillation, supraventricular tachycardia and atrial flutter), catheter ablation of ventricular arrhythmia (premature ventricular beats and ventricular tachycardia) and also other rhythm abnormalities.

Education History

Fellowship University of Utah School of Medicine
 Fellow
Baystate Medical Center
 Fellow
Residency University of Minnesota Medical School
 Resident
State University of New York Downstate Medical Center
 Intern
Professional Medical Faculty of Medicine Siriraj Hospital, Mahidol University
 MD

Selected Publications

Journal Article

  1. Jaroonpipatkul S, Trongtorsak A, Kewcharoen J, Thangjui S, Pokawattana A, Navaravong L (2024). Clarifying the association between high-sensitivity C-reactive protein and atrial fibrillation recurrence: A comprehensive response. J Arrhythm, 40(2), 391-392. (Read full article)
  2. Tokavanich N, Mongkonsritragoon W, Sattawatthamrong S, Techasatian W, Siranart N, Prasitlumkum N, Navaravong L, Chokesuwattanaskul R (2023). Outcomes of cardiac resynchronization therapy in congenital heart disease: A meta-analysis and systematic review. J Cardiovasc Electrophysiol, 35(2), 249-257. (Read full article)
  3. Tokavanich N, Techasatian W, Prasitlumkum N, Cheungpasitporn W, Navaravong L, Jongarangsin K, Chokesuwattanaskul R (2024). The efficacy and safety of cryoballoon atrial fibrillation ablation in patients with heart failure: A systematic review and meta-analysis. Indian Pacing Electrophysiol J. (Read full article)
  4. Leelaviwat N, Kewcharoen J, Trongtorsak A, Thangjui S, Del Rio-Pertuz G, Abdelnabi M, Navaravong L (2023). Association between periodontal disease and heart failure: a systematic review and meta-analysis. Acta Cardiol, 1-5. (Read full article)
  5. Leelaviwat N, Kewcharoen J, Poomprakobsri K, Trongtorsak A, Del Rio-Pertuz G, Abdelnabi M, Benjanuwattra J, Navaravong L (2023). Periodontal disease and risk of atrial fibrillation or atrial flutter: A systematic review and meta-analysis. J Arrhythm, 39(6), 992-996. (Read full article)
  6. Prasitlumkum N, Tokavanich N, Siranart N, Techasatian W, Cheungpasitporn W, Navaravong L, Chokesuwattanaskul R (2023). Atrial fibrillation catheter ablation in endurance athletes: systematic review and meta-analysis. J Interv Card Electrophysiol. (Read full article)
  7. Chai-Adisaksopha C, Watanabe AH, Dilokthornsakul P, Navaravong L, Witt DM, Chaiyakunapruk N (2023). Impact of type of anticoagulant on clinical outcomes in cancer patients who had atrial fibrillation. Sci Rep, 13(1), 10937. (Read full article)
  8. Jaroonpipatkul S, Trongtorsak A, Kewcharoen J, Thangjui S, Pokawattana A, Navaravong L (2023). High sensitivity C reactive protein levels and atrial fibrillation recurrence after catheter ablation for atrial fibrillation: A systematic review and meta-analysis. J Arrhythm, 39(4), 515-522. (Read full article)
  9. Benjanuwattra J, Kewcharoen J, Phinyo P, Swusdinaruenart S, Abdelnabi M, Del Rio-Pertuz G, Leelaviwat N, Navaravong L (2023). High-risk phenotypes of arrhythmic mitral valve prolapse: a systematic review and meta-analysis. Acta Cardiol, 1-8. (Read full article)
  10. Feuerborn ML, Dechand J, Vadlamudi RS, Torre M, Freedman RA, Groh C, Navaravong L, Ranjan R, Varela D, Bunch TJ, Steinberg BA (2022). Protocol Development and Initial Experience With Intravenous Sotalol Loading for Atrial Arrhythmias. Crit Pathw Cardiol, 22(1), 1-4. (Read full article)
  11. Tokavanich N, Prasitlumkum N, Kewcharoen J, Chokesuwattanaskul R, Phannajit J, Cheungpasitporn W, Akoum N, Ranjan R, Bunch TJ, Navaravong L (2023). Network meta-analysis and systematic review comparing efficacy and safety between very high power short duration, high power short duration, and conventional radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. (Read full article)
  12. Sessions AJ, May HT, Crandall BG, Day JD, Cutler MJ, Groh CA, Navaravong L, Ranjan R, Steinberg BA, J Bunch T (2023). Increasing time between first diagnosis of atrial fibrillation and catheter ablation adversely affects long-term outcomes in patients with and without structural heart disease. J Cardiovasc Electrophysiol. (Read full article)
  13. Siranart N, Chokesuwattanaskul R, Prasitlumkum N, Huntrakul A, Phanthong T, Sowalertrat W, Navaravong L, Cheungpasitporn W, Jongnarangsin K (2023). Reverse of left ventricular remodeling in heart failure patients with left bundle branch area pacing: Systematic review and meta-analysis. Pacing Clin Electrophysiol. (Read full article)
  14. Zenger B, Li H, Bunch TJ, Crawford C, Fang JC, Groh CA, Hess R, Navaravong L, Ranjan R, Young J, Zhang Y, Steinberg BA (2022). Major drivers of healthcare system costs and cost variability for routine atrial fibrillation ablation. Heart Rhythm O2, 4(4), 251-257. (Read full article)
  15. Prasitlumkum N, Navaravong L, Desai A, Chewcharat P, Gandhi H, Perswani P, Vallabhajosyula S, Cheungpasitporn W, Akoum N, Jongnarangsin K, Chokesuwattanaskul R (2022). Sex differences on outcomes of catheter ablation of ventricular tachycardia in patients with structural heart disease: A real-world systematic review and meta-analysis. Heart Rhythm O2, 3(6Part B), 847-856. (Read full article)
  16. Thangjui S, Yodsuwan R, Thyagaturu H, Navaravong L, Zoltick J (2022). A Prognostic Score To Predict Atrial fibrillation Recurrence After External Electrical Cardioversion-SLAC Score. Crit Pathw Cardiol, 21(4), 194-200. (Read full article)
  17. Prasitlumkum N, Navaravong L, Desai A, Desai D, Cheungpasitporn W, Rattanwong P, Bunch TJ, Jongnarangsin K, Chokesuwattanaskul R (2022). Impact of early ventricular tachycardia ablation in patients with an implantable cardioverter defibrillator: An updated systematic review and meta-analysis of randomized control trials. Heart Rhythm, 19, 2054-2061. (Read full article)
  18. Ishidoya Y, Kwan E, Dosdall DJ, Macleod RS, Navaravong L, Steinberg BA, Jared Bunch T, Ranjan R (2022). Shorter Distance Between The Esophagus And The Left Atrium Is Associated With Higher Rates Of Esophageal Thermal Injury After Radiofrequency Ablation. J Cardiovasc Electrophysiol, 33(7), 1460-1471. (Read full article)
  19. Ishidoya Y, Kwan E, Dosdall DJ, Macleod RS, Navaravong L, Steinberg BA, Jared Bunch T, Ranjan R (2022). Short-Term Natural Course of Esophageal Thermal Injury After Ablation for Atrial Fibrillation. J Cardiovasc Electrophysiol, 33(7), 1450-1459. (Read full article)
  20. Steinberg BA, Woolley S, Li H, Crawford C, Groh CA, Navaravong L, Ranjan R, Zenger B, Zhang Y, Bunch TJ (2022). Patient-reported outcomes and costs associated with vascular closure and same-day discharge following atrial fibrillation ablation. J Cardiovasc Electrophysiol, 33(8), 1737-1744. (Read full article)
  21. Prasitlumkum N, Tokavanich N, Trongtorsak A, Cheungpasitporn W, Kewcharoen J, Chokesuwattanaskul R, Akoum N, Jared Bunch T, Navaravong L (2022). Catheter ablation for atrial fibrillation in the elderly >75 years old: Systematic review and meta-analysis. J Cardiovasc Electrophysiol, 33, 1435-1449. (Read full article)
  22. Trongtorsak A, Kewcharoen J, Thangjui S, Yanez-Bello MA, Sous M, Prasai P, Navaravong L (2022). Admission hyperglycemia in acute myocardial infarction is associated with an increased risk of arrhythmias: A systematic review and meta-analysis. J Arrhythm, 38(3), 307-315. (Read full article)
  23. Muhlestein JB, Dranow E, Chaney J, Navaravong L, Steinberg BA, Freedman RA (2022). Successful avoidance of superior vena cava injury during transvenous lead extraction using a tandem femoral-superior approach. Heart Rhythm, 19, 1104-1108. (Read full article)
  24. Trongtorsak A, Kewcharoen J, Thangjui S, Yanez-Bello MA, Sous M, Prasai P, Navaravong L (2022). Admission hyperglycemia in acute myocardial infarction is associated with an increased risk of arrhythmias: A systematic review and meta-analysis. J Arrhythm. (Read full article)
  25. Burnham TS, May HT, Bair TL, Anderson JA, Crandall BG, Cutler MJ, Day JD, Freedman RA, Knowlton KU, Muhlestein JB, Navaravong L, Ranjan RA, Steinberg BA, Bunch TJ (2021). Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease. Am Heart J, 243, 127-139. (Read full article)
  26. Trongtorsak A, Kewcharoen J, Saowapa S, Polpichai N, Thangjui S, Navaravong L (2021). Comparison of mortality rates among rate-control agents in patients with atrial fibrillation: a systematic review and meta-analysis. J Cardiovasc Med (Hagerstown), 23(1), e39-e41. (Read full article)
  27. Kewcharoen J, Prasitlumkum N, Chokesuwattanaskul R, Yi R, Jongnarangsin K, Bunch TJ, Ranjan R, Navaravong L (2021). Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: An updated meta-analysis of randomized controlled trials. J Arrhythm, 37(6), 1448-1458. (Read full article)
  28. Prasitlumkum N, Cheungpasitporn W, Chokesuwattanaskul R, Kewcharoen J, Tokavanich N, Navaravong L, Jongnarangsin K (2021). Comparison between same-day discharge and overnight stay after atrial fibrillation ablation: Systematic review and meta-analysis. Pacing Clin Electrophysiol, 44(12), 2054-2066. (Read full article)
  29. Trongtorsak A, Kewcharoen J, Thangjui S, Worapongsatitaya P, Yodsuwan R, Navaravong L (2021). Same-day discharge after implantation of cardiac implantable electronic devices: A systematic review and meta-analysis. Pacing Clin Electrophysiol, 44(11), 1925-1933. (Read full article)
  30. Kanitsoraphan C, Techorueangwiwat C, Rattanawong P, Kewcharoen J, Ayinapudi K, Bunch TJ, Groh C, Navaravong L (2021). Zero fluoroscopy approach versus fluoroscopy approach for cardiac arrhythmia ablations: A systematic review and meta-analysis. J Cardiovasc Electrophysiol, 32(10), 2761-2776. (Read full article)
  31. Kewcharoen J, Prasitlumkum N, Chokesuwattanaskul R, Yi R, Jongnarangsin K, Bunch TJ, Ranjan R, Navaravong L (2021). Ablation versus medication as initial therapy for paroxysmal atrial fibrillation: An updated meta-analysis of randomized controlled trials. J Arrhythm, 37(6), 1448-1458. (Read full article)
  32. Kewcharoen J, Kanitsoraphan C, Thangjui S, Leesutipornchai T, Saowapa S, Pokawattana A, Navaravong L (2021). Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta-analysis. J Arrhythm, 37(3), 635-644. (Read full article)
  33. Kewcharoen J, Vutthikraivit W, Rattanawong P, Prasitlumkum N, Akoum NW, Bunch TJ, Navaravong L (2020). Renal sympathetic denervation in addition to pulmonary vein isolation reduces the recurrence rate of atrial fibrillation: an updated meta-analysis of randomized control trials. J Interv Card Electrophysiol, 60(3), 459-467. (Read full article)
  34. Kewcharoen J, Kanitsoraphan C, Thangjui S, Leesutipornchai T, Saowapa S, Pokawattana A, Navaravong L (2021). Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: A meta-analysis. J Arrhythm, 37(3), 635-644. (Read full article)
  35. Kewcharoen J, Techorueangwiwat C, Kanitsoraphan C, Leesutipornchai T, Akoum N, Bunch TJ, Navaravong L (2020). High-power short duration and low-power long duration in atrial fibrillation ablation: A meta-analysis. J Cardiovasc Electrophysiol, 32(1), 71-82. (Read full article)
  36. Zenger B, Zhang M, Lyons A, Bunch TJ, Fang JC, Freedman RA, Navaravong L, Piccini JP, Ranjan R, Spertus JA, Stehlik J, Turner JL, Greene T, Hess R, Steinberg BA (2020). Patient-reported outcomes and subsequent management in atrial fibrillation clinical practice: Results from the Utah mEVAL AF program. J Cardiovasc Electrophysiol, 31(12), 3187-3195. (Read full article)
  37. Suksaranjit P, McGann CJ, Akoum N, Biskupiak J, Stoddard GJ, Kholmovski EG, Navaravong L, Rassa A, Bieging E, Chang L, Haider I, Marrouche NF, Wilson BD (2016). Prognostic Implications of Left Ventricular Scar Determined by Late Gadolinium Enhanced Cardiac Magnetic Resonance in Patients With Atrial Fibrillation. Am J Cardiol, 118(7), 991-7. (Read full article)
  38. Navaravong L, Barakat M, Burgon N, Mahnkopf C, Koopmann M, Ranjan R, Kholmovski E, Marrouche N, Akoum N (2015). Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol, 26(1), 21-7. (Read full article)
  39. Navaravong L, Steenson C, Sigurdsson G (2014). Coronary plaque type and burden by computed tomography angiography without association to C-reactive protein. N Am J Med Sci, 6(6), 260-5. (Read full article)
  40. Navaravong L, Steenson C, Sigurdsson G (2014). Coronary plaque type and burden by computed tomography angiography without association to C-reactive protein. N Am J Med Sci, 6(6), 21-26. (Read full article)
  41. Ofman P, Cook JR, Navaravong L, Levine RA, Peralta A, Gaziano JM, Djousse L, Curillova Z, Hoffmeister P, Smoot K, Jiang L, Tighe DA, Stoenescu ML (2012). T-wave inversion and diastolic dysfunction in patients with electrocardiographic left ventricular hypertrophy. J Electrocardiol, 45(6), 764-9. (Read full article)

Review

  1. Crawford M, Steinberg BA, Ranjan R, Konstantinidis K, Navaravong L, Bunch TJ (2023). Mortality benefit with AF ablation: Impact of normal sinus rhythm seen in CABANA and EAST AFnet. [Review]. J Cardiovasc Electrophysiol, 35(3), 538-546. (Read full article)
  2. Trongtorsak A, Thangjui S, Adhikari P, Shrestha B, Kewcharoen J, Navaravong L, Kanjanauthai S, Attanasio S, Saudye HA (2023). Gender Disparities after Transcatheter Aortic Valve Replacement with Newer Generation Transcatheter Heart Valves: A Systematic Review and Meta-Analysis. [Review]. Med Sci (Basel), 11(2). (Read full article)
  3. Thangjui S, Thyagaturu H, Trongtorsak A, Yodsuwan R, Fayaz M, Kewcharoen J, Navaravong L (2023). Electrical Cardioversion-Associated Takotsubo Cardiomyopathy: A National Readmission Database 2018 Analysis and Systematic Review. [Review]. Anatol J Cardiol, 27(2), 62-68. (Read full article)
  4. Sim R, Chong CW, Loganadan NK, Fong AYY, Navaravong L, Hussein Z, Khunti K, Lee SWH (2022). Comparative effectiveness of cardiovascular, renal and safety outcomes of second-line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta-analysis of randomised controlled trials. [Review]. Diabet Med, 39(3), e14780. (Read full article)
  5. Watanabe AH, Navaravong L, Sirilak T, Prasitwarachot R, Nathisuwan S, Page RL 2nd, Chaiyakunapruk N (2021). A systematic review and meta-analysis of randomized controlled trials of cardiovascular toxicity of medical cannabinoids. [Review]. J Am Pharm Assoc (2003), 61(5), e1-e13. (Read full article)
  6. Navaravong L, Ranjan R (2020). Role of Imaging in Improving Outcomes with Ablation. [Review]. Curr Treat Options Cardiovasc Med, 22(10). (Read full article)

Book Chapter

  1. Leenhapong Navaravong, Nassir Marrouche (April 2019). Chapter 49 - Magnetic Resonance Imaging Mapping of Atrial Fibrosis and Atrial Fibrillation. In Mohammad Shenasa MD, PhD, Gerhard Hindricks MD, David J. Callans MD, John M. Miller MD, Mark E. Josephson MD, (Eds.), Cardiac Mapping (5th edition). John Wiley & Sons Ltd.
  2. Navaravong L, Marrouche NF (2019). Magnetic resonance imaging mapping of atrial fibrosis and atrial fibrillation. In Navaravong L|Marrouche NF (Ed.), Cardiac Mapping (pp. 618-627). (Read full article)
  3. Leenhapong Navaravong, Nassir Marroucher (February 2019). CMR Guidance of RFA to Atrial Arrhythmias. In Raymond Y. KwongMichael Jerosch-HeroldBobak Heydari (Ed.), Cardiovascular Magnetic Resonance Imaging (2nd). Springr Link.
  4. Navaravong L, Freedman RA (2017). How to Extract Pacemaker and Defibrillator Leads from the Femoral Approach. In Al‐Ahmad A, Natale A, Wang PJ, Daubert JP, Padeletti L (Eds.), How‐to Manual for Pacemaker and ICD Devices: Procedures and Programming (pp. 79-87).
  5. Navaravong L, Marrouche N (2015). MRI definition of atrial substrate. In Navaravong L|Marrouche N (Ed.), Practical Guide to Catheter Ablation of Atrial Fibrillation: Second Edition (pp. 101-108). (Read full article)

Case Report

  1. Prasitlumkum N, Pai RG, Navaravong L (2022). Chest Pain With a Bizarre Electrocardiogram: Swiveling Around the Axis. Cureus, 14(4), e24191. (Read full article)
  2. Leenhapong Navaravong MD (September 2018). FEATURED CASE Managing Heart Failure in a Complex Young Patient. EP Lab Dig, 18(9).
  3. Navaravong L, Akoum N (2015). An unusual response to para-Hisian pacing: what is the mechanism? J Cardiovasc Electrophysiol, 26(3), 354-6. (Read full article)

Letter

  1. Thangjui S, Thyagaturu H, Trongtorsak A, Yodsuwan R, Fayaz M, Kewcharoen J, Navaravong L (2023). Reply to Letter to the Editor: 'Diabetes mellitus as a protective factor in Takotsubo Cardiomyopathy'. [Letter to the editor]. Anatol J Cardiol, 27(6), 371. (Read full article)
  2. Sessions AJ, May HT, Crandall BG, Day JD, Cutler MJ, Groh CA, Navaravong L, Ranjan R, Steinberg BA, Jared Bunch T (2023). Response to "Delay in AF ablation costs lives". [Letter to the editor]. J Cardiovasc Electrophysiol, 34(4), 1094-1095. (Read full article)
  3. Akoum N, Navaravong L (2014). Chronic kidney disease should not exclude patients with low atrial fibrosis from catheter ablation therapy for atrial fibrillation. [Letter to the editor]. J Cardiovasc Electrophysiol, 25(12), E8. (Read full article)
  4. Navaravong L, Larson BW, Chandrashekhar Y (2014). Exercise induced changes in VEGF and NT-proBNP and relationship to exercise induced ischemia. [Letter to the editor]. Int J Cardiol, 174(1), 137-8. (Read full article)

Other

  1. Lotfi A, Shakoor M, Ahmed M, Daoulah A, Navaravong L, Hiser W, Knee A (2019). Ankle-Brachial Index in Addition to Stress Testing in Patients Who Presented With Chest Pain and 1-Year Major Cardiovascular Events. Crit Pathw Cardiol (18(4), pp. 189-194). United States. (Read full article)

Video/Film/CD/Web/Podcast

  1. El-Chami M, Armbruster AL, Banthia S, Campbell KB, Navaravong L, Panna ME Jr (May 2018). El-Chami M, Armbruster AL, Banthia S, Campbell KB, Navaravong L, Panna ME Jr. Supraventricular Tachycardia: Understand Your Condition. May 2018. https://www.cardiosmart.org/Heart-Conditions/Supraventricular-Tachycardia/Understand-Your-Condition. [Web].